Chimerix Inc (NASDAQ:CMRX) shares traded 219.08% higher at $2.76 on Wall Street last session.
CMRX stock price is now 192.33% away from the 50-day moving average and 190.71% away from the 200-day moving average. The market capitalization of the company currently stands at $248.21M.
With the price target of $7, Robert W. Baird recently initiated with Outperform rating for Chimerix Inc (NASDAQ: CMRX). On September 07, 2022, CapitalOne recently initiated its ‘Overweight’ rating on the stock quoting a target price of $7, while ‘Maxim Group’ rates the stock as ‘Buy’
In other news, Michael Andriole, Officer bought 1,500 shares of the company’s stock on Aug 08 ’24. The stock was bought for $1,300 at an average price of $0.87. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 08 ’24, PRESIDENT AND CEO Andriole Michael T. sold 1,285 shares of the business’s stock. A total of $1,065 was realized by selling the stock at an average price of $0.83. This leaves the insider owning 462,453 shares of the company worth $1.28 million. A total of 10.93% of the company’s stock is owned by insiders.
During the past 12 months, Chimerix Inc has had a low of $0.75 and a high of $1.30. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 6.33, and a quick ratio of 6.33. The fifty day moving average price for CMRX is $0.9078 and a two-hundred day moving average price translates $0.94175 for the stock.
The latest earnings results from Chimerix Inc (NASDAQ: CMRX) was released for 2024-09-30. The net profit margin was -52574.84% and return on equity was -48.59% for CMRX. The company reported revenue of $26000.0 for the quarter, compared to $11000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 136.36 percent.
